Weight-loss drugs have become massively popular over the last few years, but drug manufacturers have regularly taken heat for how expensive these medications are and how difficult they can be to ...

A recent study published in PNAS explores the potential benefits of expanding access to novel weight loss drugs to enhance survival rates in overweight and obese individuals. Study: Estimating the ...

“We have to be mindful of the side effects that we are seeing with the new weight loss medications, such as a person eating less while on the medications and not getting the appropriate amount ...

John Yang: Physicians are increasingly using weight loss drugs to treat obesity, diabetes and other chronic conditions in young people, including children. In the last three years, the number of ...

Novo and rival Eli Lilly, which makes the GLP-1 weight-loss drug Zepbound, have reaped billions of dollars in profits since their new drugs hit the U.S. market, with only a fraction of an ...

Recent developments in healthcare cover a broad spectrum of issues: an analysis reveals that weight-loss drugs like Wegovy do not reduce long-term health costs, and an E. coli outbreak linked to ...

Ozempic and other GLP-1 drugs show promise not only in managing ... The results were consistent across age, gender, and weight. The brain contains GLP-1 receptors, which can be activated to ...

WASHINGTON — Despite the celebrity status “miracle” weight loss drugs like Ozempic and Wegovy have gained recently, it appears most Americans are not jumping at the chance to use them. A recent ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found.

A box containing injectable vials of the weight-loss drug Wegovy in Brighton, Mich. on June 8, 2023. (CYDNI ELLEDGE) ...